Powder: -20°C for 3 years | In solvent: -80°C for 1 year
C12-Ceramide (C12 Ceramide (d18:1/12:0)), a ceramide present in the protective membranes surrounding umbilical cord blood vessels in infants born to women with pre-eclampsia, can be used to assess the level of ASM activity in the plasma of patients with Niemann-Pick disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 147.00 | |
10 mg | In stock | $ 239.00 | |
25 mg | In stock | $ 395.00 |
Description | C12-Ceramide (C12 Ceramide (d18:1/12:0)), a ceramide present in the protective membranes surrounding umbilical cord blood vessels in infants born to women with pre-eclampsia, can be used to assess the level of ASM activity in the plasma of patients with Niemann-Pick disease. |
Synonyms | N-Laurylsphingosine, C12 Ceramide (d18:1/12:0), N-Lauroyl-D-erythro-sphingosine |
Molecular Weight | 481.79 |
Formula | C30H59NO3 |
CAS No. | 74713-60-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: >33 mg/mL
DMF: 22 mg/mL
DMSO: 20 mg/mL
PBS (pH 7.2): <50μg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
C12-Ceramide 74713-60-3 C12 Ceramide d18:1/12:0 N-Laurylsphingosine C12 Ceramide (d18:1/12:0) N-Lauroyl-D-erythro-sphingosine C12Ceramide C-12-Ceramide inhibitor inhibit